Last $20.17 USD
Change Today -0.31 / -1.51%
Volume 363.7K
AMED On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 8:10 PM 09/30/14 All times are local (Market data is delayed by at least 15 minutes).

amedisys inc (AMED) Snapshot

Open
$20.49
Previous Close
$20.48
Day High
$20.75
Day Low
$20.10
52 Week High
08/5/14 - $22.58
52 Week Low
11/13/13 - $12.60
Market Cap
670.3M
Average Volume 10 Days
297.8K
EPS TTM
$0.10
Shares Outstanding
33.2M
EX-Date
--
P/E TM
207.6x
Dividend
--
Dividend Yield
--
Current Stock Chart for AMEDISYS INC (AMED)

amedisys inc (AMED) Related Businessweek News

View More BusinessWeek News

amedisys inc (AMED) Details

Amedisys Inc. provides home health and hospice services including practical nursing services and physical and occupational therapy. The company’s services also comprise speech pathology, social work to help families address acute and chronic illnesses, home health aide services, and private duty services. Hospice services use a team made up of a physician, patient care manager, registered nurses, certified home health aides, social workers, a chaplain, a homemaker, and volunteers. As of Apr. 4, 2007, the company operated 261 Medicare-certified home health agencies and 14 Medicare-certified hospice agencies in 19 states. Amedisys was founded in 1982 and is headquartered in Baton Rouge, La.

14,300 Employees
Last Reported Date: 03/12/14
Founded in 1982

amedisys inc (AMED) Top Compensated Officers

Interim Chief Executive Officer, President an...
Total Annual Compensation: $514.2K
Chief Medical Officer
Total Annual Compensation: $308.5K
Senior Vice President, General Counsel and Co...
Total Annual Compensation: $277.3K
Chief Compliance Officer
Total Annual Compensation: $270.6K
Compensation as of Fiscal Year 2013.

amedisys inc (AMED) Key Developments

Amedisys Inc. Announces Board Changes

On August 28, 2014, David R. Pitts, 75, non-executive Co-Chairman of the Board of Directors (the Board) of Amedisys Inc., informed the Company of his intent to retire from the Board, effective August 31, 2014. The Board accepted Mr. Pitts' decision. Following Mr. Pitts' announcement of his retirement from the Board, the Board determined that the Company would be best served by having a single independent Chairman, and elected Donald A. Washburn, formerly non-executive Co-Chairman of the Board, and before that the Company's independent Lead Director, to serve as non-executive Chairman of the Board.

Amedisys Inc. Presents at Baird's 2014 Healthcare Conference, Sep-03-2014 01:10 PM

Amedisys Inc. Presents at Baird's 2014 Healthcare Conference, Sep-03-2014 01:10 PM. Venue: The New York Palace, New York, New York, United States. Speakers: Ronald A. LaBorde, Interim Chief Executive Officer, President and Director.

Amedisys Inc. Reports Unaudited Consolidated Financial Results for the Second Quarter and Six Months Ended June 30, 2014; Records Other Intangibles Impairment Charge for the Second Quarter Ended June 30, 2014

Amedisys Inc. reported unaudited consolidated financial results for the second quarter and six months ended June 30, 2014. For the quarter, the company reported net service revenue was $305,006,000 against $315,960,000 for the same period last year. Operating income was $12,561,000 against $4,250,000 for the same period last year. Income before income taxes was $12,353,000 against $3,047,000 for the same period last year. Income from continuing operations was $7,610,000 or $0.23 diluted per share against $2,005,000 or $0.06 diluted per share for the same period last year. Net income attributable to Amedisys Inc. was $7,619,000 or $0.23 diluted per share against $1,841,000 or $0.06 diluted per share for the same period last year. Net cash used in operating activities was $89,129,000 compared with net cash provided by operating activities of $33,561,000 for the same period last year. EBITDA was $21,329,000 against $13,454,000 for the same period last year. Adjusted EBITDA was $22,113,000 against $19,587,000 for the same period last year. Adjusted net income from continuing operations attributable to Amedisys Inc. was $8,040,000 or $0.25 diluted per share against $5,775,000 or $0.18 diluted per share for the same period last year. For the six months, the company reported net service revenue was $603,745,000 against $644,562,000 for the same period last year. Operating loss was $7,012,000 against operating income of $9,617,000 for the same period last year. Loss before income taxes was $7,498,000 against income before income taxes of $8,055,000 for the same period last year. Loss from continuing operations was $4,623,000 or $0.14 diluted per share against income from continuing operations of $4,862,000 or $0.17 diluted per share for the same period last year. Net loss attributable to Amedisys Inc. was $4,798,000 or $0.15 diluted per share against net income attributable to Amedisys Inc. of $4,519,000 or $0.14 diluted per share for the same period last year. Net cash used in operating activities was $95,471,000 compared with net cash provided by operating activities of $65,977,000 for the same period last year. EBITDA was $10,728,000 against $29,759,000 for the same period last year. Adjusted EBITDA was $27,612,000 against $37,923,000 for the same period last year. Adjusted net income from continuing operations attributable to Amedisys Inc. was $5,818,000 or $0.18 diluted per share against $10,429,000 or $0.33 diluted per share for the same period last year. The company recorded other intangibles impairment charge of $2,286,000 compared with $1,408,000 for the same period last year.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AMED:US $20.17 USD -0.31

AMED Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Almost Family Inc $27.17 USD -0.34
BioScrip Inc $6.91 USD 0.00
Chemed Corp $102.90 USD -1.21
LHC Group Inc $23.20 USD -0.43
SunLink Health Systems Inc $1.47 USD +0.03
View Industry Companies
 

Industry Analysis

AMED

Industry Average

Valuation AMED Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.6x
Price/Book 1.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMEDISYS INC, please visit www.amedisys.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.